Keeping up with FDA updates isn’t easy—and finding the time to make sense of them in the middle of a busy pharmacy day is even harder.
That’s why we created Med Intel with Michelle, a content series featuring on-demand resources curated by one of our on-staff pharmacists, Michelle Barney, PharmD, that breaks down what’s changing and why it matters for you and your patients.
-1.gif?width=400&height=225&name=download%20(1)-1.gif)
In this Q1 recap, Michelle walks through recent FDA approvals, label expansions, and regulatory updates—focusing on what’s most relevant for community pharmacy today, including GLP-1 therapies, new oral weight-loss options, expanded uses of familiar medications, and key FDA enforcement changes.
We've designed the information to be consumed however is easiest for you:
Listen to the audio-only version while you work or drive to your store
Download the slides and save them to reference whenever you need them